Pirisudanol

Pirisudanol
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral
ATC code N06BX08 (WHO)
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 33605-94-6 YesY
PubChem (CID) 65782
ChemSpider 59202
UNII W618Z2SMVL YesY
KEGG D07347 YesY
ECHA InfoCard 100.046.887
Chemical and physical data
Formula C16H24N2O6
Molar mass 340.372 g/mol
3D model (Jmol) Interactive image
  (verify)

Pirisudanol (Mentis, Menthen, Mentium, Nadex, Nadexen, Nadexon, Pridana, Stivane), also known as pyrisuccideanol, is the succinic acid ester of pyridoxine (a form of vitamin B6) and of deanol (DMAE).[1] It has been used in Europe in the treatment of mild cognitive impairment as well as fatigue and depression.[1][2][3][4][5]

See also

References

  1. 1 2 [+http://www.dr-bob.org/cgi-bin/pb/mget.pl?post=/babble/20010708/msgs/69493.html#69493 "Psycho-Babble Medication Thread 69493"] Check |url= value (help).
  2. David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
  3. Bathien N, Willer JC, Hugelin A (1976). "[Effect of psychotropic drugs on physiological variations and psychometric scores during attention]". L'Encéphale (in French). 2 (1): 55–60. PMID 1261486.
  4. Murphy JE (1981). "An evaluation of pyrisuccideanol maleate (Nadex) in the treatment of mild to moderate depression in patients aged 55 years and over, presenting in general practice". The Journal of International Medical Research. 9 (5): 330–7. PMID 7297757.
  5. Zmorski T (September 1983). "[Experience with Nadex in an ambulatory psychiatric practice]". Therapeutische Umschau. Revue Thérapeutique (in German). 40 (9): 817–20. PMID 6138876.


This article is issued from Wikipedia - version of the 10/16/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.